Author

T. Dao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 2 Microbiology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Organism:human· 4 Assay:proteomics· 4 Research Focus:cell type annotation· 3 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:plant (other)· 1

Frequent Co-Authors

D. A. Scheinberg· 4 shared M. G. Klatt· 3 shared R. S. Gejman· 2 shared S. S. Mun· 2 shared T. Korontsvit· 2 shared A. Charles· 1 shared A. Daman· 1 shared A. McKnight· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

D. A. Scheinberg

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles

Z. Molvi, M. G. Klatt, T. Dao, J. Urraca, D. A. Scheinberg, R. J. O'Reilly

This study identifies tumor-specific phosphopeptides presented by multiple HLA alleles, showing allele-specific immunogenicity differences for cancer immunotherapy.

Journal for ImmunoTherapy of Cancer · Sep 28, 2023Peer-reviewedImmunology

Spatial Co-transcriptomics Reveals Discrete Stages of the Arbuscular Mycorrhizal Symbiosis

K. Serrano, M. Bezrutczyk, D. Goudeau, T. Dao, R. C. O'Malley, R. R. Malmstrom, A. Visel, H. V. Scheller, B. Cole

This study uses spatial transcriptomics to analyze the molecular stages of arbuscular mycorrhizal symbiosis in plant roots.

bioRxiv · Aug 2, 2023Plant Biology

Pneumococcal Evasion of Antibiotics via Metabolic Adaptation During Infection

T. Dao, H. Echlin, A. McKnight, E. Marr, J. Junker, Q. Jia, R. Hayden, J. Rosch

This study shows that S. pneumoniae evades fluoroquinolone antibiotics through metabolic adaptation that reduces reactive oxygen species production, enabling tolerance and fitness restoration.

bioRxiv · Apr 14, 2022 · PreprintMicrobiology

Unmasking the cryptic immunopeptidome of EZH2 mutated diffuse large B-cell lymphomas through combination drug treatment

C. M. Bourne, S. S. Mun, T. Dao, Z. E. H. Aretz, R. S. Gejman, A. Daman, K. Takata, C. Steidl, M. G. Klatt, D. A. Scheinberg

The paper identifies tumor-specific MHC ligands in EZH2-mutated DLBCLs by combining epigenetic drugs and interferon gamma, expanding the immunopeptidome for immunotherapy targets.

bioRxiv · Sep 1, 2021 · PreprintImmunology

Low-Dose CDK4/6 Inhibitors Induce Presentation of Pathway Specific MHC ligands as Targets for Cancer Immunotherapy

A. Charles, C. Bourne, S. S. Mun, T. Dao, Z. Aretz, T. Korontsvit, M. Klatt, D. A. Scheinberg

This study shows low-dose CDK4/6 inhibitors increase HLA ligand presentation from cell cycle proteins, creating potential targets for immunotherapy in breast cancer.

bioRxiv · Jun 18, 2020Cancer Biology

Identification of the targets of T cell receptor therapeutic agents and cells by use of a high throughput genetic platform

R. S. Gejman, H. F. Jones, M. G. Klatt, A. Y. Chang, C. Y. Oh, S. S. Chandran, T. Korontsvit, V. Zakahleva, T. Dao, C. A. Klebanoff, D. A. Scheinberg

This study introduces a high-throughput genetic platform to identify on- and off-targets of T cell receptor therapeutic agents using MHC-I ligands.

bioRxiv · Sep 1, 2019Cancer Biology